Safety and efficacy of two-port thoracoscopic aortic valve replacement.

ABSTRACT:

Background

Pure aortic valve disease is common and has been treated with sternotomy aortic valve replacement for decades. Minimally invasive cardiac surgery has been widely used in atrioventricular valve lesions, but totally thoracoscopic aortic valve replacement has rarely been reported.

Method

The profiles of 9 patients who were diagnosed with severe aortic valve diseases and treated with two-port thoracoscopic aortic valve replacement between February 2021 and February 2022 were retrospectively reviewed. The clinical data, including baseline characteristics, operative data, postoperative complications, and short-term outcomes, were reported.

Results

All nine patients successfully underwent two-port thoracoscopic aortic valve replacement, with a cardiopulmonary bypa

SUBMITTER: Tan T 

PROVIDER: S-EPMC9824918 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature